If you are considering divesting one or more brands or the whole portfolio in any therapeutic or geographic area, please contact DESMA PHARMA Group for a preliminary assessment More
Solvay Pharmaceuticals is seeking to in-license late stage or filed/marketed products to commercialize in the emerging markets including Brazil, Mexico, Turkey, China, India and Russia. More
Our client is interested in hearing from clients who wish to change the site of manufacturing and package the following dosage forms; Tablets, Capsules, Effervescent tablets and Liquid injections. More